Fraunhofer Institute for Toxicology and Experimental Medicine
Bringing a new drug from early discovery to clinical application is a complex journey – one that requires deep mechanistic understanding, predictive models, and robust safety assessment.
At Fraunhofer ITEM, we bridge this gap. Our expertise in preclinical pharmacology and toxicology enables us to translate biological mechanisms into actionable data for decision-making in drug development. From advanced in vitro systems to translational in vivo models, we support our partners in developing safer and more effective therapies.
With our new webinar series, “From Mechanism to Market – Translational Strategies in Preclinical Pharmacology and Toxicology,” we open the door to our scientific approaches, technologies, and services.
Each session will provide a focused deep dive into a specific area of expertise – demonstrating how we help to address key challenges in pharmaceutical research and development.
